S&P Global
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions and AI monetisation.
$DIS making a comeback attempt from "fallen angel" status...
@challeyok You can go look at the GFC performance for $PSA The coverage ratio is 6.1x, will need NOI/EBITDA to fall over 80% before they have distribution issues
For Passive Income folks I think the $PSA Prefs yielding 7.3% is the best risk reward and have a 11% price appreciation upsde. I went back and looked at spreads/coverage ratios going back to early 2000s Not everyone's cup of tea, but great for passive income Seriously thinking about putting 30% to 100% of my MIL/FIL IRA in these
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term…
Deckers Outdoor trades at 12 times trailing earnings as HOKA and UGG grow, while buybacks could retire 8% of shares and support EPS.
Steve Eisman, Dan Ives and Gil Luria assess how the midterms could reshape AI data-center spending, Google search growth, and competition…
Reddit's search-traffic selloff overlooks that logged-in app users generate more than 80% of monetization, supporting a $130 one-year…
FactSet CEO Sanoke Viswanathan discusses using the firm’s client relationships and data platform to deploy AI across finance.
Accenture reported 6.5% FY26 revenue growth and $11.6 billion in free cash flow, while fixed-price contracts above 65% of bookings retain…
Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.
Ondas reported $167.5 million in Q3 revenue but spent $562 million of cash, halved gross margin and fell below its $6 stop level.
Offshore Radar maps 160-plus listed offshore rigs, contracts, day rates and uncontracted capacity through 2029.
Travere Therapeutics' FILSPARI has two FDA approvals and is driving revenue growth, while TVTX shares have nearly tripled since August 2025.
Research Roundup covers AAON's data-center cooling ramp, Knife River's margin recovery, ChronoScale's Microsoft-backed neocloud buildout…
Annaly Capital Management’s rate swaps and MBS expansion lifted earnings available for distribution 28% year over year, supporting its…
Asia's elevator boom favors maintenance and modernization providers, with Otis deriving nearly 90% of operating profit from after-sales…
Portfolio returned 65.7% through September 28 versus the S&P 500’s 13.2%, while backing Tourmaline, EQT, Athabasca and SLB on gas demand…
FTAI Aviation’s engine-exchange model swaps CFM56 engines in days rather than 200-day overhauls, driving Aerospace Products adjusted EBITDA…
The Trade Desk’s CEO received a new 10-year option package targeting $105 per share as the company seeks shareholder approval to reprice…
Beam Therapeutics’ BEAM-302 AATD gene-editing program anchors its 2028–2029 upside, while a 2–3 year cash runway leaves dilution likely…
Alpha Metallurgical Resources director Ken Courtis bought $10.5 million above $190 after a blackout lifted, while Conifer’s 12.7% Group 1…
Robinhood’s long-term value rests on retaining customer assets and becoming a primary financial platform beyond trading.
Cisco’s Sam Badri says roughly 90% of AI users remain at basic prompting, with few advancing to skills files or AI agents.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.